ProQR Therapeutics NV Expert Perspectives Call Transcript
Good afternoon, and welcome to the ProQR Expert Perspectives Call. (Operator Instructions) Today's call is being recorded, and a replay will be made available on the ProQR website following the event.
At this time, I would like to turn the call over to Daniel de Boer, Founder and Chief Executive Officer of ProQR for some introductory remarks. Please go ahead, Daniel.
Thank you, Sarah, and good afternoon, and good morning, everyone, wherever you are. Welcome to today's expert perspective call. At ProQR, we work every day to create transformative RNA therapies for severe genetic and rare indications.
For those on the call today that may be just learning about us, we are a biotechnology company that is headquartered in Leiden in the Netherlands, and we have a U.S. site in Cambridge, Massachusetts. While our RNA oligonucleotides platform has brought applicability, our focus is on the development of medicines for inherited retinal diseases.
We have a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |